Schedule 13G/A

260 Schedule 13G/A filing by Fidelity / FMR

Fidelity / FMR reported beneficial ownership of 11.0M shares, representing 12.2% of CENTESSA PHARMACEUTICALS-ADR in this filing.

FiledFeb 6, 2026

Ownership dateJan 30, 2026

Reported shares11.0M

Reported ownership12.2%

Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 11.0M

Shared voting power 11.0M

Sole dispositive power 11.0M

Shared dispositive power 11.0M

Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer: Fidelity / FMR
CIK: CIK0000315066
Accession: 0000315066-26-000600
Form: Schedule 13G/A

Open SEC filing View 260 ownership history

Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →